Home Nav
Nextech Invest Logo

Kristina Kakalacheva

Alfred Scheidegger

Prior to joining Nextech in 2014, Dr. Kakalacheva developed scientific expertise in immuno-oncology through various research projects. She holds a PhD from the University of Zurich, Switzerland where she researched virus-associated malignancies and led an academia-based drug discovery project. She completed a MSc in integrated immunology from the University of Oxford, UK. During these studies, she performed research at the Jenner Institute for Vaccine Design and the Wellcome Trust Center for Human Genetics in Oxford, UK.


Swiss Biotech Day



  • 20.04.2017

    Jounce Therapeutics initiates Phase 2 portion of ICONIC...

  • 19.04.2017

    Kura Oncology granted U.S. patent for clinical-stage...

  • 10.04.2017

    Tracon awarded 'Most Innovative Trial Design' for Phase...


Newsletter Registration

Please fill in the subscription form completely. If you wish to modify your personal data or to change/cancel your newsletter subscription, this is possible at any time.

A link to your subscription profile can be found in every newsletter email.


* Compulsory fields


Newsletter Registration

Your eMail have been successfully registered.